Felix C Osanu
Examiner (ID: 8640)
Most Active Art Unit | 3635 |
Art Unit(s) | 4112, 3635 |
Total Applications | 6 |
Issued Applications | 0 |
Pending Applications | 0 |
Abandoned Applications | 6 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 4410108
[patent_doc_number] => 06228835
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-08
[patent_title] => 'Decorin binding protein compositions'
[patent_app_type] => 1
[patent_app_number] => 9/221938
[patent_app_country] => US
[patent_app_date] => 1998-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 25
[patent_no_of_words] => 40738
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/228/06228835.pdf
[firstpage_image] =>[orig_patent_app_number] => 221938
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/221938 | Decorin binding protein compositions | Dec 27, 1998 | Issued |
Array
(
[id] => 1527828
[patent_doc_number] => 06479235
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-12
[patent_title] => 'Multiplex amplification of short tandem repeat loci'
[patent_app_type] => B1
[patent_app_number] => 09/199542
[patent_app_country] => US
[patent_app_date] => 1998-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17742
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/479/06479235.pdf
[firstpage_image] =>[orig_patent_app_number] => 09199542
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/199542 | Multiplex amplification of short tandem repeat loci | Nov 24, 1998 | Issued |
Array
(
[id] => 4240866
[patent_doc_number] => 06090912
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-18
[patent_title] => 'Topologically segregated, encoded solid phase libraries comprising linkers having an enzymatically susceptible bond'
[patent_app_type] => 1
[patent_app_number] => 9/198209
[patent_app_country] => US
[patent_app_date] => 1998-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 39482
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/090/06090912.pdf
[firstpage_image] =>[orig_patent_app_number] => 198209
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/198209 | Topologically segregated, encoded solid phase libraries comprising linkers having an enzymatically susceptible bond | Nov 22, 1998 | Issued |
Array
(
[id] => 1544707
[patent_doc_number] => 06444423
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'Nucleosides comprising polydentate ligands'
[patent_app_type] => B1
[patent_app_number] => 09/191785
[patent_app_country] => US
[patent_app_date] => 1998-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 43
[patent_no_of_words] => 24692
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444423.pdf
[firstpage_image] =>[orig_patent_app_number] => 09191785
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/191785 | Nucleosides comprising polydentate ligands | Nov 12, 1998 | Issued |
Array
(
[id] => 1477353
[patent_doc_number] => 06344318
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-05
[patent_title] => 'Methods of producing nucleic acid ligands'
[patent_app_type] => B1
[patent_app_number] => 09/165616
[patent_app_country] => US
[patent_app_date] => 1998-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 42
[patent_no_of_words] => 20692
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/344/06344318.pdf
[firstpage_image] =>[orig_patent_app_number] => 09165616
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/165616 | Methods of producing nucleic acid ligands | Oct 1, 1998 | Issued |
Array
(
[id] => 7640027
[patent_doc_number] => 06395888
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-28
[patent_title] => 'High affinity nucleic acid ligands of complement system proteins'
[patent_app_type] => B1
[patent_app_number] => 09/163025
[patent_app_country] => US
[patent_app_date] => 1998-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 19176
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/395/06395888.pdf
[firstpage_image] =>[orig_patent_app_number] => 09163025
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/163025 | High affinity nucleic acid ligands of complement system proteins | Sep 28, 1998 | Issued |
Array
(
[id] => 1433298
[patent_doc_number] => 06340588
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-22
[patent_title] => 'Matrices with memories'
[patent_app_type] => B1
[patent_app_number] => 09/051022
[patent_app_country] => US
[patent_app_date] => 1998-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 23
[patent_no_of_words] => 86981
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/340/06340588.pdf
[firstpage_image] =>[orig_patent_app_number] => 09051022
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/051022 | Matrices with memories | Sep 21, 1998 | Issued |
Array
(
[id] => 4096696
[patent_doc_number] => 06048698
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-11
[patent_title] => 'Parallel SELEX.TM.'
[patent_app_type] => 1
[patent_app_number] => 9/157601
[patent_app_country] => US
[patent_app_date] => 1998-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 21
[patent_no_of_words] => 31231
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/048/06048698.pdf
[firstpage_image] =>[orig_patent_app_number] => 157601
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/157601 | Parallel SELEX.TM. | Sep 20, 1998 | Issued |
09/156824 | HIGH-AFFINITY OLIGONUCLEOTIDE LIGANDS TO VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) | Sep 17, 1998 | Abandoned |
Array
(
[id] => 1520543
[patent_doc_number] => 06413764
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-02
[patent_title] => 'Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/153757
[patent_app_country] => US
[patent_app_date] => 1998-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 38848
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/413/06413764.pdf
[firstpage_image] =>[orig_patent_app_number] => 09153757
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/153757 | Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof | Sep 14, 1998 | Issued |
Array
(
[id] => 4335117
[patent_doc_number] => 06333153
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-25
[patent_title] => 'Compositions, kits, and methods for effecting adenine nucleotide modulation of DNA mismatch recognition proteins'
[patent_app_type] => 1
[patent_app_number] => 9/143571
[patent_app_country] => US
[patent_app_date] => 1998-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 49
[patent_no_of_words] => 45610
[patent_no_of_claims] => 88
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/333/06333153.pdf
[firstpage_image] =>[orig_patent_app_number] => 143571
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/143571 | Compositions, kits, and methods for effecting adenine nucleotide modulation of DNA mismatch recognition proteins | Aug 27, 1998 | Issued |
Array
(
[id] => 4216231
[patent_doc_number] => 06110900
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-29
[patent_title] => 'Nucleic acid ligands'
[patent_app_type] => 1
[patent_app_number] => 9/143190
[patent_app_country] => US
[patent_app_date] => 1998-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 38
[patent_no_of_words] => 50182
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/110/06110900.pdf
[firstpage_image] =>[orig_patent_app_number] => 143190
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/143190 | Nucleic acid ligands | Aug 26, 1998 | Issued |
09/129134 | DETERMINING COMMON FUNCTIONAL ALLELES IN A POPULATION AND USES THEREFORE | Aug 3, 1998 | Abandoned |
Array
(
[id] => 1565034
[patent_doc_number] => 06376175
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-23
[patent_title] => 'Methods of discovering chemicals capable of functioning as gene expression modulators'
[patent_app_type] => B1
[patent_app_number] => 09/123728
[patent_app_country] => US
[patent_app_date] => 1998-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 61
[patent_no_of_words] => 32019
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/376/06376175.pdf
[firstpage_image] =>[orig_patent_app_number] => 09123728
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/123728 | Methods of discovering chemicals capable of functioning as gene expression modulators | Jul 27, 1998 | Issued |
09/120533 | NUCLEIC ACID COMPOSITIONS AND METHODS OF INTRODUCING NUCLEIC ACIDS INTO CELLS | Jul 21, 1998 | Abandoned |
Array
(
[id] => 4342902
[patent_doc_number] => 06214355
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'DbpA compositions'
[patent_app_type] => 1
[patent_app_number] => 9/117257
[patent_app_country] => US
[patent_app_date] => 1998-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 34
[patent_no_of_words] => 50750
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214355.pdf
[firstpage_image] =>[orig_patent_app_number] => 117257
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/117257 | DbpA compositions | Jul 21, 1998 | Issued |
Array
(
[id] => 1593783
[patent_doc_number] => 06383743
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-07
[patent_title] => 'Method for serial analysis of gene expression'
[patent_app_type] => B1
[patent_app_number] => 09/107228
[patent_app_country] => US
[patent_app_date] => 1998-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 9589
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/383/06383743.pdf
[firstpage_image] =>[orig_patent_app_number] => 09107228
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/107228 | Method for serial analysis of gene expression | Jun 29, 1998 | Issued |
Array
(
[id] => 4115411
[patent_doc_number] => 06071699
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-06
[patent_title] => 'Nucleic acid mediated electron transfer'
[patent_app_type] => 1
[patent_app_number] => 9/100507
[patent_app_country] => US
[patent_app_date] => 1998-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 36
[patent_no_of_words] => 19477
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/071/06071699.pdf
[firstpage_image] =>[orig_patent_app_number] => 100507
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/100507 | Nucleic acid mediated electron transfer | Jun 18, 1998 | Issued |
Array
(
[id] => 1542006
[patent_doc_number] => 06372428
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-16
[patent_title] => 'Remotely programmable matrices with memories'
[patent_app_type] => B1
[patent_app_number] => 09/098122
[patent_app_country] => US
[patent_app_date] => 1998-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 34533
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/372/06372428.pdf
[firstpage_image] =>[orig_patent_app_number] => 09098122
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/098122 | Remotely programmable matrices with memories | Jun 15, 1998 | Issued |
Array
(
[id] => 3908939
[patent_doc_number] => 06001577
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-14
[patent_title] => 'Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex'
[patent_app_type] => 1
[patent_app_number] => 9/093293
[patent_app_country] => US
[patent_app_date] => 1998-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 29
[patent_no_of_words] => 23512
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 280
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/001/06001577.pdf
[firstpage_image] =>[orig_patent_app_number] => 093293
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/093293 | Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex | Jun 7, 1998 | Issued |